News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

Esaxerenone produces favourable night-time BP-lowering effect in Asians
24 Jan 2022
byJairia Dela Cruz
The novel highly selective mineralocorticoid receptor blocker esaxerenone holds promise in the treatment of nocturnal hypertension, yielding substantial reductions in night-time blood pressure (BP), especially in Japanese patients with a riser pattern, as well as in N-terminal pro B-type natriuretic peptide (NT-proBNP) levels, according to a post hoc analysis of a phase III study.
24 Jan 2022







